ClinicalTrials.gg
Active, not recruitingNCT07034846Updated Nov 5, 2026

Investigation of the Effects of Respiratory Muscle Training Combined With Otago Exercises in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery

An interventional study of High-intensity intermittent IMT and Otago Exercises Group and Sham IMT and Otago Exercises Group in Coronary Artery Bypass Graft (CABG), sponsored by Istanbul University - Cerrahpasa. Active, not recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

How we know

Updated Nov 5, 2026Now Active, not recruitingStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 81 studies in Motor Activity by Istanbul University - Cerrahpasa — 26 open to participants now, 28 under way, none of them phase 3. Motor Activity · Istanbul University - Cerrahpasa.

Planned enrollment
54th of 62
28 · median 42
Started
2025
with 9 others
No phase
62 of 81
18 open now
Primary completion
2026-11
later than 16 of 27 live
Registered
66th of 81
by date

Among the 81 studies in Motor Activity by Istanbul University - Cerrahpasa, this one is the 54th largest by planned enrollment of the 62 interventional ones that give a count, is one of 10 that started in 2025, is one of 62 with no phase, reaches primary completion later than 16 of the 27 other live ones, and was the 66th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

26 of the 81 studies in Motor Activity by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

21 more — sign in →

By country, each count listing its studies:

All 26 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Motor Activity by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

A review of the literature suggests that high-intensity intermittent inspiratory muscle training (IMT) combined with the Otago exercise program may provide positive effects on early post-discharge recovery of patients aged 65 years and older undergoing coronary artery bypass graft (CABG) surgery. No studies have yet examined the effects of high-intensity intermittent IMT combined with the Otago exercise program on patients undergoing CABG surgery. This study is the first to evaluate the effects of high-intensity intermittent IMT combined with the Otago exercise program on pulmonary function, functional capacity, muscle strength, functional mobility, balance, anxiety and depression levels, frailty, and quality of life in elderly patients undergoing CABG surgery.

Read the detailed description

Coronary artery bypass graft (CABG) surgery aims to revascularize the myocardium by bypassing one or more coronary arteries narrowed or occluded due to atherosclerosis. Procedures such as sternotomy, cardiopulmonary bypass, general anesthesia, and pleural drain placement can lead to postoperative complications including hypersecretion, hypoxemia, decreased pulmonary compliance, reduced exercise capacity, and impaired lung function. These complications may cause prolonged immobilization and additional pulmonary issues. Moreover, protein catabolism after cardiovascular surgery leads to muscle protein loss, which is exacerbated by immobilization, slowing protein synthesis and accelerating muscle fiber breakdown and cell death, thereby contributing to muscle loss progression. Postural balance also decreases following CABG, potentially leading to reduced functional activities, increased fall risk, morbidity, and mortality. CABG negatively impacts patients' quality of life and causes functional limitations. Anxiety about disease recurrence and fear of death after discharge contribute to psychological stress for patients and relatives, further impairing recovery.

Frailty is closely associated with cardiopulmonary diseases and is common after CABG surgery. A study evaluating 180 bypass patients with an average age of approximately 69 years found that 23.3% were frail. High frailty scores post-CABG correlate with adverse outcomes such as prolonged hospital stays and rehospitalization within 30 days.

Inspiratory muscle training (IMT) is a method designed to strengthen inspiratory muscles by providing airway resistance during breathing. Effective IMT requires appropriate intensity, duration, and frequency. Training at or above 30% of maximal inspiratory pressure (MIP) for 20-30 minutes daily, five days a week, over 5-12 weeks produces structural changes in respiratory muscles.

Previous studies demonstrated that IMT improves inspiratory muscle strength, functional capacity, psychosocial status, and quality of life in patients undergoing CABG surgery. Additionally, moderate to high-intensity IMT combined with aerobic and strengthening exercises during cardiac rehabilitation increases exercise capacity, inspiratory muscle strength, and quality of life more than sham IMT combined with similar exercises.

High-intensity intermittent IMT has recently shown beneficial results in cardiovascular and pulmonary diseases. In heart failure patients, high-intensity intermittent IMT performed in cycles of loading and rest improved dyspnea, frailty, fatigue, inspiratory muscle strength, respiratory muscle endurance, exercise capacity, and quality of life, compared to sham IMT. Similar positive effects were observed in patients with bronchiectasis and elderly individuals undergoing home-based IMT, with improvements in inspiratory muscle function, balance, and physical performance.

IMT has demonstrated effectiveness in reducing dyspnea, improving respiratory muscle strength, pulmonary function, functional capacity, daily living activities, and quality of life in patients with chronic obstructive pulmonary disease, chronic kidney disease, chronic heart failure, and in healthy populations. It also enhances postural stability due to the diaphragm's mechanical role in lumbar stabilization.

The Otago exercise program, developed in New Zealand to prevent falls, is a home-based training protocol including warm-up, strengthening, balance, and walking exercises. Performed three times weekly with progressively increasing intensity, it improves lower extremity muscle strength, balance, and mobility in elderly individuals.

Few studies have investigated the combination of IMT and the Otago exercise program. Recent research in healthy adults and diabetic patients indicates that combined training improves balance, inspiratory muscle function, mobility, respiratory function, muscle strength, and endurance more than either intervention alone.

This prospective, randomized, controlled, single-blind study will evaluate the effects of the Otago exercise program combined with high-intensity IMT on elderly patients undergoing CABG surgery. The study will be conducted at Istanbul University-Cerrahpaşa Cardiology Institute, Department of Cardiovascular Surgery.

03

Conditions studied

  • Coronary Artery Bypass Graft (CABG)

Browse trials for

Keywords

  • Exercise
  • Inspiratory muscle training
  • Otago Exercises
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 65 years and older undergoing coronary artery bypass graft surgery
  • Hospital discharge realized (post operative ≥ 2 weeks)
  • No for exercise training
  • Not concurrently participating in another exercise training program
  • Have the means to enter a home-based rehabilitation program
  • Patients who agree to participate voluntarily will be included in the study program.

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular instability (aortic dissection, unstable angina pectoris, acute decompensated heart failure, acute pericarditis or myocarditis, severe cardiac arrhythmia, ventricular aneurysm)
  • Uncontrolled hypertension and diabetes mellitus
  • Diagnosed with chronic lung disease
  • Cognitive impairment that prevents them from communicating with the physiotherapist
  • Failure to maintain the exercise training program
  • Patients with severe orthopedic or neurological disorders will not be included.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
28 participants (estimated)

Study arms

  • Experimental
    High-intensity intermittent IMT and Otago Exercises Group

    Patients aged 65 years and over who have undergone CABG surgery and who are at least 2 weeks postoperatively and who meet the inclusion criteria will be identified. Then, patients who volunteer to participate in the study will be referred.

    Other: High-intensity intermittent IMT and Otago Exercises Group

  • Active comparator
    Sham IMT and Otago Exercises Group

    Patients aged 65 years and over who have undergone CABG surgery and who are at least 2 weeks postoperatively and who meet the inclusion criteria will be identified. Then, patients who volunteer to participate in the study will be referred.

    Other: Sham IMT and Otago Exercises Group

Interventions

  • OtherHigh-intensity intermittent IMT and Otago Exercises Group

    Patients in the experimental group will perform 7 sets of high-intensity intermittent inspiratory muscle training (IMT) for eight weeks, one day a week face-to-face with the researcher and two days at home, for a total of three days, each set consisting of 2 minutes of loading and 1 minute of rest for a total of 21 minutes. The Otago exercise program will be conducted for eight weeks, two days a week home-based and one day face-to-face with the researcher. The Otago exercise program will be complemented with walking exercise every day of the week. The Otago exercise program is designed to be progressive. The protocol was created to increase the difficulty of training at four different levels and every 2 weeks. The Otago exercise program will be applied to both the experimental group and the control group in the same protocol.

    Also known as: High-intensity intermittent IMT group

  • OtherSham IMT and Otago Exercises Group

    Patients in the control group will perform 7 sets of sham inspiratory muscle training (IMT), consisting of 2 minutes of loading and 1 minute of rest in each set for a total of 21 minutes, one day a week face-to-face with the researcher and two days at home, for eight weeks. The Otago exercise program will be conducted for eight weeks, two days a week home-based and one day face-to-face with the researcher. The Otago exercise program will be complemented with walking exercise every day of the week. The Otago exercise program is designed to be progressive. The protocol was created to increase the difficulty of training at four different levels and every 2 weeks. The Otago exercise program will be applied to both the experimental group and the control group in the same protocol.

    Also known as: Sham IMT group

06

What researchers measure

Primary outcomes

  1. Maximum inspiratory pressure

    In the maximum inspiratory pressure measurement, patients will be asked to perform maximum inspiration for at least 2 seconds through the mouthpiece after first performing maximum expiration by sitting and using a nose clip. The measurement result will be recorded in units of cmH2O and percentage % of the expected value. The measurement will be considered satisfactory when a change of less than 10% is observed between the three measurements and the highest value is adopted.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

Secondary outcomes

  1. Maximum expiratory pressure

    Patients will be asked to perform maximum expiration against a closed system for at least 2 seconds after maximum inspiration. The measurement result will be recorded in units of cmH2O and percentage % of the expected value. The measurement will be considered satisfactory when a change of less than 10% is observed between the three measurements and the highest value is adopted.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  2. Forced vital capacity (FVC) massessment

    Patients will perform a rapid and complete inhalation maneuver from functional residual capacity to total lung capacity, followed by a continuous and maximal exhalation maneuver lasting at least six seconds. Verbal and non-verbal encouragement will be provided throughout the maneuvers. The test will be terminated once acceptable repeatability is achieved. The results will be recorded in litres.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  3. Assessment of functional capacity

    Functional capacity will be assessed using the 6-Minute Walk Test. Patients will be instructed to walk at their own pace to cover the maximum possible distance along a 30-meter corridor within 6 minutes. The total distance walked will be recorded in meters. Heart rate, measured in beats per minute, blood pressure, measured in millimeters of mercury, and oxygen saturation, measured as a percentage, will be recorded both before and after the test. Patients will be informed that they may rest or slow down as needed during the test.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  4. Evaluation of muscle strength

    Isometric muscle strength of the M. Quadriceps femoris will be measured using a portable handheld dynamometer. Patients will be seated with the knee in full extension, and maximum resistance will be applied at the ankle to assess muscle strength. The measurement will be repeated three consecutive times, and the average value will be recorded in kilograms.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  5. Assessment of functional mobility

    Mobility will be assessed using the Timed Up and Go Test. Patients will be instructed to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. The total time taken to complete this task will be recorded in seconds. A time of 13.5 seconds or longer is indicative of a higher risk of falls.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  6. Balance assessment

    Balance performance will be assessed using the Berg Balance Scale, which consists of 14 items scored from 0 to 4, with a maximum total score of 56. Scores between 0-20 indicate balance impairment, 21-40 indicate acceptable balance, and 41-56 indicate good balance performance. Additionally, balance confidence will be evaluated using the Activity Specific Balance Confidence Scale, which includes 16 questions assessing confidence in performing daily activities indoors and outdoors. Each item is scored from 0% (unsafe) to 100% (completely safe), and the average score is calculated to provide an overall balance confidence percentage. Higher scores represent greater confidence.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  7. Assessment of anxiety and depression level

    Anxiety and depression levels will be assessed using the Hospital Anxiety and Depression Scale. This scale evaluates the risk and severity of anxiety and depression symptoms through 14 questions-seven assessing anxiety (odd-numbered) and seven assessing depression (even-numbered). Responses are rated on a four-point Likert scale ranging from 0 to 3. The total score ranges from 0 to 42. Higher scores indicate more severe symptoms.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  8. Frailty assessment

    Frailty will be assessed using the Fried Frailty Phenotype based on five criteria: Participants with three or more criteria will be classified as frail.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  9. Assessment of quality of life

    Patients' quality of life will be assessed using the Short Form-36 questionnaire, which comprises 36 items covering eight subscales related to physical and mental health. Each subscale is scored between 0 and 100, with higher scores indicating a better overall quality of life.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  10. Forced expiratory volume in one second (FEV1) assessment

    Patients will perform a rapid and complete inhalation maneuver from functional residual capacity to total lung capacity, followed by a continuous and maximal exhalation maneuver lasting at least six seconds. Verbal and non-verbal encouragement will be provided throughout the maneuvers. The test will be terminated once acceptable repeatability is achieved. The results will be recorded in litres.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  11. FEV1/FVC ratio

    FVC and FEV1 results will be compared and expressed as percentages.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  12. Forced expiratory flow 25-75% (FEF25-75) assessment

    Patients will perform a rapid and complete inhalation maneuver from functional residual capacity to total lung capacity, followed by a continuous and maximal exhalation maneuver lasting at least six seconds. Verbal and non-verbal encouragement will be provided throughout the maneuvers. The test will be terminated once acceptable repeatability is achieved. The results will be expressed in litres per second.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

  13. Peak expiratory flow (PEF) assessment

    Patients will perform a rapid and complete inhalation maneuver from functional residual capacity to total lung capacity, followed by a continuous and maximal exhalation maneuver lasting at least six seconds. Verbal and non-verbal encouragement will be provided throughout the maneuvers. The test will be terminated once acceptable repeatability is achieved. The results will be expressed in litres per minute.

    Time frame: The baseline assessment will be conducted at 2 weeks post-surgery. Following the completion of the 8-week intervention protocol, the final assessment will be performed at 10 weeks post-surgery.

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data, including all measurement data collected in the study, will be shared with researchers upon request. The data will become available after the completion of the study and publication of the results, and will remain accessible for 5 years thereafter. Researchers may request access via email at celebisaemre@gmail.com. No formal approval process will be required to obtain the data.

Supporting information: Study protocol

Time frame: IPD and supporting information will be available beginning in June 2025 and will remain accessible through June 2030.

Access criteria: Access to de-identified individual participant data (IPD) and supporting information will be available to qualified researchers upon request. Researchers interested in accessing the data may contact via email at celebisaemre@gmail.com. There will be no requirement to submit a formal research proposal, data sharing agreement, or obtain prior approval. The data provided will include all measurement data collected in the study, de-identified to protect participant privacy. Requests will be handled on a first-come, first-served basis and no independent review or committee approval is necessary. The data may be used for secondary analyses, validation studies, or meta-analyses.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Nov 2026, 18 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 18 months is close to that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start Jul 2025 → May 2025, primary completion Jun 2026 → Nov 2026 and completion Jul 2026 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2025
First posted
Jun 24, 2025
StartActual
May 13, 2025was Jul 2025
Primary completionEst.
Nov 25, 2026was Jun 2026
CompletionEst.
Nov 25, 2026was Jul 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Active, not recruiting
changed Nov 5, 2026
Sites
1 site removed
Show 1 removed
  • Istanbul University-Cerrahpaşa · Istanbul, Turkey (Türkiye)
Nov 5, 2026
Start date
Jul 1, 2025→May 13, 2025 (actual)
Nov 5, 2026
Primary completion
Jun 1, 2026→Nov 25, 2026
Nov 5, 2026
Study completion
Jul 1, 2026→Nov 25, 2026
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Active, not recruiting
    1 site removed
    Show 1 removed
    • Istanbul University-Cerrahpaşa · Istanbul, Turkey (Türkiye)
    Start date Jul 1, 2025→May 13, 2025 (now actual)
    Primary completion Jun 1, 2026→Nov 25, 2026
    Study completion Jul 1, 2026→Nov 25, 2026
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07034846
Responsible party
Sadık Emre ÇELEBİ (MSc, PhD(c), Physiotherapist, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Jun 24, 2025
Start date
May 13, 2025
Primary completion
Nov 25, 2026 (estimated)
Completion
Nov 25, 2026 (estimated)
Last update
Nov 5, 2026

Study contacts

Rengin Demir, Professor
study director · Istanbul University-Cerrahpaşa, Cardiology Institute, Department of Cardiology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion